A calcineurin inhibitor, FK506, blocks voltage-gated calcium channel-dependent LTP in the hippocampus

Neurosci Res. 1998 Apr;30(4):313-9. doi: 10.1016/s0168-0102(98)00012-1.

Abstract

The effects of FK506, an immunosuppressant and protein phosphatase 2B (calcineurin) inhibitor, on the voltage-gated calcium channel (VGCC)-dependent long-term potentiation (LTP) were investigated in the CA1 region of mice hippocampal slices. VGCC-dependent LTP was induced either by a brief application of a potassium channel blocker tetraethyleneanmonium (TEA), or by a strong tetanic stimulation under the blockade of NMDA-receptors. FK506 (1-50 microM) produced dose-dependent inhibition on TEA-induced LTP. Cyclosporin A (CysA 50 microM), another calcineurin inhibitor, showed a similar inhibitory effect on TEA-induced LTP. FK506 (10 microM) also blocked the strong tetanus-induced LTP, but had no effect on the post-tetanic potentiation. By using a subthreshold weak tetanic stimulation protocol, we also found that low concentration of FK506 (1 microM) produced neither inhibition nor potentiation on VGCC-dependent LTP. These results showed FK506 and CysA exerted inhibitory effects on VGCC-dependent LTP, and suggest that calcineurin is involved in the processes of this kind of synaptic plasticity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcineurin Inhibitors*
  • Calcium Channel Blockers / pharmacology*
  • Calcium Channels / physiology*
  • Cyclosporine / pharmacology
  • Dose-Response Relationship, Drug
  • Electric Stimulation
  • Hippocampus / chemistry
  • Hippocampus / physiology
  • Immunosuppressive Agents / pharmacology*
  • Ion Channel Gating / physiology
  • Long-Term Potentiation / drug effects*
  • Long-Term Potentiation / physiology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Nifedipine / pharmacology
  • Tacrolimus / pharmacology*
  • Tetraethylammonium / pharmacology

Substances

  • Calcineurin Inhibitors
  • Calcium Channel Blockers
  • Calcium Channels
  • Immunosuppressive Agents
  • Tetraethylammonium
  • Cyclosporine
  • Nifedipine
  • Tacrolimus